FIG. 2.
Percentage distribution of photodynamic inactivation (PDI) responders across Staphylococcus aureus groups revealing various antimicrobial resistance mechanisms. R, resistant; IS, intermediate sensitive, S, sensitive (PDI responders). RF, rifamycines, FA, fusidic acid; TCs, tetracyclines; OXAZ, oxazolidinone; AGs, aminoglycosides; TMP-SMX, trimethoprim/sulfamethoxazole; MLSB, macrolides, lincosamides, streptogramins B; KAN, kanamycin; TOB, tobramycin; GEN; gentamycin.